SEC filing · 8-K

Transcode Therapeutics, Inc.: Material agreement

TransCode Therapeutics made an $840,975 prepayment to Yorkville to obtain a waiver for an amortization event under its convertible notes.

Filed October 1, 2026

Negative for the company

What happened

Between September 11, 2026 and September 30, 2026, the daily VWAP of the common stock was below the $1.72 floor price for 10 out of 14 trading days.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Transcode Therapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.